U07.1
Conditions
Interventions
Group 1: All COVID-19 patients in participating ICUs will be included. Patient-based data of all COVID-19 patient comprise admission quarter of the year, sex, day of COVID-19 diagnose, day of positive
Sponsors
Projektträger JülichGründungs-, Technologietransfer- und InnovationsförderungInternationales Forschungszentrum Jülich GmbH
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients diagnosed with COVID-19 (on admission or during their ICU stay)
Exclusion criteria
Exclusion criteria: Patients without COVID-19 and patients without admission to the participating ICU
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Incidence and incidence densitiy (per 1000 patient days or per 1000 device-days) of ICU-acquired change of microorganism in existing respiratory infections -Incidence and incidence density of new ICU-acquired respiratory infections -Incidence and incidence density of new ICU-acquired blood stream infections -Incidence and incidence densities of new ICU-acquired multidrug-resistant organisms (Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci, multidrug-resistant Gram-negative bacteria) | — |
Secondary
| Measure | Time frame |
|---|---|
| -Admission prevalence of respiratory tract infections -Rates of device use (invasive ventilation, non-invasive ventilation, central venous catheter, extracorporal membranous oxygenation) -Incidence of secondary blood stream infections in patients with respiratory infections | — |
Countries
Germany
Contacts
Public ContactFriederike Maechler
Charité Campus Benjamin FranklinInstitut für Hygiene und UmweltmedizinNationales Referenzzentrum für Nosokomiale Infektionen
Outcome results
None listed